Evidence map›Paper›PMID 26696902›Full record

ArticleFrontiers in physiology2015

Development of an Experimental Model to Study the Relationship Between Day-to-Day Variability in Blood Pressure and Aortic Stiffness.

Camille Bouissou-Schurtz, Georges Lindesay, Véronique Regnault, Sophie Renet, Michel E Safar, Vincent Molinie, Hubert Dabire, Yvonnick Bezie

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Measuring Arterial Stiffness in Animal Experimental Studies.Arteriosclerosis, thrombosis, and vascular biology · 2020
    Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Camille Bouissou-SchurtzInstitut National de la Santé et de la Recherche Médicale, U955, Equipe 03 Créteil, France.
Georges LindesayCardiovascular Department, Institut de Recherches Servier Suresnes, France.
Véronique RegnaultInstitut National de la Santé et de la Recherche Médicale, U1116 Nancy, France.
Sophie RenetGroupe Hospitalier Paris Saint-Joseph, Department of Pharmacy Paris, France.
Michel E SafarCentre de Diagnostic et Université René Descartes, Hôtel-Dieu Hospital, UFR Médecine Paris, France.
Vincent MolinieDepartment of Pathology, Centre Hospitalier Universitaire La Meynard Fort de France, France.
Hubert DabireInstitut National de la Santé et de la Recherche Médicale, U955, Equipe 03 Créteil, France.
Yvonnick BezieGroupe Hospitalier Paris Saint-Joseph, Department of Pharmacy Paris, France.
Hôpital Paris Saint-Joseph · FRCentre de Recherche en Sciences et Technologies de l'Information et de la Communication · FRCentre Hospitalier Universitaire de Martinique · MQDéfaillance Cardiovasculaire Aiguë et ChroniqueInstitut de Relations Internationales et Stratégiques · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to develop an animal model of long-term blood pressure variability (BPV) and to investigate its consequences on aortic damage. We hypothesized that day-to-day BPV produced by discontinuous treatment of spontaneously hypertensive rats (SHR) by valsartan may increase arterial stiffness. For that purpose, rats were discontinuously treated, 2 days a week, or continuously treated by valsartan (30 mg/kg/d in chow) or placebo. Telemetered BP was recorded during 2 min every 15 min, 3 days a week during 8 weeks to cover the full BP variations in response to the treatment schedule. Pulse wave velocity (PWV) and aortic structure evaluated by immunohistochemistry were investigated in a second set of rats treated under the same conditions. Continuous treatment with valsartan reduced systolic BP (SBP) and reversed the aortic structural alterations observed in placebo treated SHR (decrease of medial cross-sectional area). Discontinuous treatment with valsartan decreased SBP to a similar extent but increased the day-to-day BPV, short term BPV, diastolic blood pressure (DBP), and PWV as compared with continuous treatment. Despite no modifications in the elastin/collagen ratio and aortic thickness, an increase in PWV was observed following discontinuous treatment and was associated with a specific accumulation of fibronectin and its αv-integrin receptor compared with both groups of rats. Taken together the present results indicate that a discontinuous treatment with valsartan is able to induce a significant increase in day-to-day BPV coupled to an aortic phenotype close to that observed in hypertension. This experimental model should pave the way for future experimental and clinical studies aimed at assessing how long-term BPV increases aortic stiffness.

Indexed as

aortic stiffnessdiastolic blood pressurefibronectinlong-term blood pressure variabilitypulse wave velocityspontaneously hypertensive ratstelemetry

Identifiers

PMID26696902
PMCPMC4672044
OpenAlexW2238088650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.